Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein A: use in first-trimester screening for Down syndrome.
Screening for Down syndrome in the first trimester by a combination of fetal nuchal translucency thickness and maternal serum pregnancy-associated plasma protein A (PAPP-A) and free beta-human chorionic gonadotropin has been shown to be effective and efficient. We aimed to develop a fast point-of-care assay that could be placed in one-stop clinics for the measurement of PAPP-A. We developed a two-site, one-step assay that uses two monoclonal antibodies (mAbs) to PAPP-A, based on a dry-reagent, all-in-one immunoassay concept with a stable fluorescent lanthanide chelate and time-resolved fluorometry. One antibody (mAb 10E1) was biotinylated, and the other (mAb 234-5) was europium-labeled, both via the epsilon-amino groups of surface lysine residues. The assay was performed on an AIO immunoanalyzer at 36 degrees C in single, streptavidin-coated microtitration wells that contained the dry reagents. PAPP-A, either in free or complexed form, was detected by the antibodies used. The assay procedure required 20 min and used 10 microL of sample. The calibration curve was linear from 5 to 10 000 mIU/L. The detection limit was 0.5 mIU/L. Intra- and interassay imprecision (CV) was < or = 4.3% and 8.3%, respectively, for whole blood, plasma, or serum samples. Recovery was 93-96% for serum, 95-108% for heparin-derived whole blood, and 98-103% for heparin-derived plasma. Parallelism was observed in all three matrices. Results correlated [slope = 0.85 (confidence interval, 0.82-0.87); intercept = -33 (confidence interval, -58 to -9); S(y:x) = 85 mIU/L; r = 0.991; n = 100] with those obtained by a Delfia assay. Heparin did not affect the assay, but EDTA markedly reduced PAPP-A values. PAPP-A was stable at 4 degrees C for at least 18 days in serum and for 8 days in heparin-derived whole blood or plasma. The present assay appears suited for use in one-stop clinics for screening for Down syndrome in the first trimester, with results available within 1 h.